I1DX34 Stock Overview
Develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
IDEXX Laboratories, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$485.25 |
| 52 Week High | US$575.20 |
| 52 Week Low | US$436.04 |
| Beta | 1.27 |
| 1 Month Change | -5.04% |
| 3 Month Change | -12.72% |
| 1 Year Change | 2.37% |
| 3 Year Change | -12.04% |
| 5 Year Change | n/a |
| Change since IPO | 107.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| I1DX34 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | -1.4% | 0.05% | -0.8% |
| 1Y | 2.4% | -0.05% | 10.5% |
Return vs Industry: I1DX34 exceeded the BR Medical Equipment industry which returned -1.1% over the past year.
Return vs Market: I1DX34 underperformed the BR Market which returned 9.7% over the past year.
Price Volatility
| I1DX34 volatility | |
|---|---|
| I1DX34 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in BR Market | 9.0% |
| 10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: I1DX34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine I1DX34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 11,000 | Jay Mazelsky | www.idexx.com |
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community.
IDEXX Laboratories, Inc. Fundamentals Summary
| I1DX34 fundamental statistics | |
|---|---|
| Market cap | R$213.12b |
| Earnings (TTM) | R$4.45b |
| Revenue (TTM) | R$19.11b |
49.7x
P/E Ratio11.6x
P/S RatioIs I1DX34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| I1DX34 income statement (TTM) | |
|---|---|
| Revenue | US$3.72b |
| Cost of Revenue | US$1.48b |
| Gross Profit | US$2.24b |
| Other Expenses | US$1.37b |
| Earnings | US$866.57m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 06, 2024
| Earnings per share (EPS) | 10.49 |
| Gross Margin | 60.14% |
| Net Profit Margin | 23.26% |
| Debt/Equity Ratio | 60.3% |
How did I1DX34 perform over the long term?
See historical performance and comparison